NCT03236688View on ClinicalTrials.gov

Detection of ARv7 in the Plasma of Men With Advanced Metastatic Castrate Resistant Prostate Cancer (MCRP)

SuspendedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
Metastatic Castrate Resistant Prostate Cancer
Trial Locations (1)

06520

Yale University School of Medicine, New Haven

Sponsors
All Listed Sponsors
collaborator

Yale University

OTHER

lead

Exosome Diagnostics, Inc.

INDUSTRY

NCT03236688 - Detection of ARv7 in the Plasma of Men With Advanced Metastatic Castrate Resistant Prostate Cancer (MCRP) | Biotech Hunter | Biotech Hunter